<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1601256669
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VENTOLIN 0.5MG\ML INJ
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SALBUTAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXOSMITHKLINE (GSK)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXOSMITHKLINE (GSK)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Glaxo Saudi Arabia Ltd.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R03CC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Ventolin Injection contains a medicine called salbutamol. This belongs to a group of medicines called bronchodilators.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchodilators help the airways in your lungs to stay open. This makes it easier for air to get in and out.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; They help to relieve chest tightness, wheezing and cough.</p><p>&nbsp;</p><p>Ventolin Injection is used to treat severe breathing problems in people with asthma and similar conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Ventolin Injection:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to salbutamol Sulphate or any of the other ingredients of this medicine (listed in Section 6)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you unexpectedly go into early labour (premature labour) or threatened abortion</p><p>Do not take if the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Ventolin Injection.</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, nurse or pharmacist before taking your medicine if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have high blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are diabetic</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an overactive thyroid gland</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a history of heart problems such as an irregular or fast heartbeat or angina</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;you are taking xanthine derivatives (such as theophylline) or steroids to treat asthma</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are taking water tablets (diuretics), sometimes used to treat high blood pressure or a heart condition</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have taken other drugs used to relieve stuffy nose (such as ephedrine or pseudoephedrine) or other medicines used to treat asthma</p><p>&nbsp;</p><p><strong>Other medicines and Ventolin Injection</strong></p><p>Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines.</p><p>In particular tell your doctor or pharmacist if you are taking:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for an irregular or fast heartbeat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other medicines for your asthma</p><p>&nbsp;</p><p>Ventolin Injection should not be administered in the same syringe as any other medication.</p><p>&nbsp;</p><p><strong>Using Ventolin Injection with food and drink</strong></p><p>You can use Ventolin Injection at any time of day, with or without food.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or are breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines </strong></p><p>Ventolin Injection is not likely to affect you being able to drive or use any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How your Injection is given</strong></p><p>Ventolin Injection is usually given to you by a doctor or nurse. It can be given under the skin (subcutaneously) or directly into a vein or muscle (intravenous or intramuscular route). You will never be expected to give yourself this medicine. It will always be given to you by a person who is qualified to do so.</p><p>&nbsp;</p><p>The ampoules are equipped with the OPC (One Point Cut) opening system and must be opened using the following instructions:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hold with one hand the bottom part of the ampoule</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; put the other hand on the top of the ampoule positioning the thumb above the coloured point and press</p><p><strong>&nbsp;</strong></p><p><strong>Subcutaneous or Intramuscular route</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is 8 micrograms per kilogram body weight every four hours</p><p>&nbsp;</p><p><strong>Slow Intravenous injection</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is 4 micrograms per kilogram body weight</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This will be injected slowly and may be repeated if necessary</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ventolin Injection may be diluted with 10 ml Water for Injections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 ml of the diluted preparation (250&nbsp;micrograms per 5 ml) may be administered by slow intravenous injection</p><p>&nbsp;</p><p>Ventolin Injection is not suitable for treating children under 12 years of age.</p><p><strong>&nbsp;</strong></p><p><strong>If you receive more Ventolin Injection than you should</strong></p><p>Ventolin Injection will always be given under carefully controlled conditions. However, if you think that you have been given more than you should tell your doctor or nurse as soon as possible.</p><p>The following effects may happen:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your heart beating faster than usual</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you feel shaky</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hyperactivity</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acid build up in your body which may cause your breathing to become faster</p><p>These effects usually wear off in a few hours.</p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking Ventolin Injection</strong></p><p>Do not stop taking Ventolin Injection without talking to your doctor.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Ventolin Injection can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:</p><p><strong>Allergic reactions</strong> (affects less than 1 in 10,000 people)</p><p>If you have an allergic reaction, stop taking Ventolin Injection and see a doctor straight away. Signs of an allergic reaction include: swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing, itchy rash, feeling faint and light headed, and collapse.</p><p><strong>&nbsp;</strong></p><p><strong>Talk to your doctor as soon as possible if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you feel your heart is beating faster or stronger than usual (palpitations). This is usually harmless, and usually stops after you have used the medicine for a while</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you may feel your heartbeat is uneven or it gives an extra beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; these affect less than 1 in 10 people</p><p>If any of these happen to you, talk to your doctor as soon as possible. <strong>Do not stop using this medicine unless told to do so</strong>.</p><p>&nbsp;</p><p>Tell your doctor if you have any of the following side effects, which may also happen with this medicine:</p><p><strong>Very common</strong> (may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling shaky</p><p><strong>&nbsp;</strong></p><p><strong>Common</strong> (may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle cramps</p><p>&nbsp;</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients receiving Ventolin Injection for the treatment of premature labour: cough, wheezing, chest pain or shortness of breath, which may be signs of pulmonary oedema (fluid in the lungs). Tell your doctor immediately</p><p>&nbsp;</p><p><strong>Rare</strong> (may affect up to 1 in 1,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a low level of potassium in your blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased blood flow to your extremities (peripheral dilatation)</p><p><strong>&nbsp;</strong></p><p><strong>Very rare</strong> (may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in sleep patterns and changes in behaviour, such as restlessness and excitability</p><p>&nbsp;</p><p><strong>The following side effects can also happen but the frequency of these are not known:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stinging or pain when the injection is given directly into the muscle</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick and being sick (nausea and vomiting)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain, due to heart problems such as angina. Tell your doctor, nurse or pharmacist if this occurs. Do not stop using this medicine unless told to do so</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a condition known as lactic acidosis which may cause stomach pain, hyperventilation, shortness of breath, cold feet and hands, irregular heartbeat or thirst</p><p>&nbsp;</p><p><strong>If you think this medicine is not working well enough for you</strong></p><p>If your medicine does not seem to be working as well as usual, talk to your doctor as soon as possible. Your chest problem may be getting worse and you may need a different medicine. Do not take extra Ventolin Injection unless your doctor tells you to.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the ampoules in the outer carton to protect from light</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use the medicine within 24 hours of mixing with infusion fluids</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date, which is stated on the ampoule label and carton after &lsquo;EXP&rsquo;. The expiry date refers to the last day of that month</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are told to stop taking this medicine return any unused Ventolin Injection to your pharmacist to be destroyed</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Ventolin Injection contains</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is salbutamol Sulphate</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are water, salt (sodium chloride), sodium hydroxide, sulfuric acid, nitrogen</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Ventolin Injection looks like and contents of the pack
Ventolin Injection comes in a 1 ml glass ampoule in plastic trays of five. 
5 ml contains 2.5 mg of salbutamol (as salbutamol Sulphate) in sterile normal saline adjusted to pH 3.5
Each carton contains 5 ampoules

Using Instructions 

The only recommended diluents for Ventolin Injection are water for injections BP, sodium chloride injection BP, sodium chloride and dextrose injection BP or dextrose injection BP.

All unused admixtures of Ventolin Injection should be discarded 24 hours after preparation.

Ventolin Injection should not be administered in the same syringe as any other medication.

VENTOLIN is IV is a trademark owned by or licensed to GSK group of companies
© 2019 GSK group of companies.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer </strong></p><p>GlaxoSmithKline Manufacturing S.p.A.*, Parma, Italy</p><p><strong>Marketing Authorisation Holder</strong></p><p>GlaxoSmithKline Manufacturing S.p.A.*, Parma, Italy</p><p>* member of the GlaxoSmithKline group of companies</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version Number: UK 06
Date of issue: 29 Oct 2014

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي فينتولين حقن على دواء يُسمى سالبوتامول&rlm;‫. وهو ينتمي إلى فئة من الأدوية تسمى موسعات الشعب الهوائية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساعد موسعات الشعب الهوائية على إبقاء الشُعب الهوائية في الرئتين مفتوحة. وهو ما يُسهل دخول الهواء وخروجه.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وهي تساعد على تخفيف ضيق الصدر والأ&rlm;‫زيز الصدري والسعال.</p><p dir="RTL">يُستعمل فينتولين حقن لعلاج مشاكل التنفس الحادة في الأشخاص الذين يعانون من الربو أو من حالات مماثلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستعمل فينتولين حقن في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية لكبريتات سالبوتامول أو أي من المكوّنات الأخرى لهذا الدواء (المدرجة في القسم 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا دخلتِ في حالة ولادة غير متوقعة (ولادة مبكرة) أو كنتِ مهددة بالإجهاض</p><p dir="RTL">لا تستخدم الدواء إذا كان أي مما سبق ينطبق عليك. إذا لم تكن متأكدًا، استشر الطبيب أو الصيدلاني قبل استخدام فينتولين حقن.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">استشر الطبيب أو الممرضة أو الصيدلاني قبل استخدام الدواء إذا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من ارتفاع في ضغط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مصابًا بمرض السكري</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من فرط نشاط الغدة الدرقية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك تاريخ مرضي يتعلق بمشاكل في القلب، مثل عدم انتظام أو سرعة ضربات القلب أو الذبحة الصدرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;كنت تتناول مشتقات الزانتين (مثل الثيوفيلين) أو ستيرويدات لعلاج الربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول أقراصًا مائية (مدرة للبول)، والتي تُستعمل أحيانًا لعلاج ارتفاع ضغط الدم أو مرض في القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول أدوية أخرى تُستعمل لعلاج احتقان الأنف (مثل الإيفيدرين أو السودوإيفيدرين) أو غيرها من الأدوية المستخدمة لعلاج الربو</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى و</strong><strong>&rlm;</strong>‫<strong>فينتولين حقن</strong><strong>&rlm;</strong>‫</p><p dir="RTL">أخبر الطبيب أو الممرضة أو الصيدلاني إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، بما في ذلك الأدوية التي يتم تناولها بدون وصفة طبية. وهذا يشمل الأعشاب الطبية.</p><p dir="RTL">وبصفة خاصة، أخبر الطبيب أو الصيدلاني إذا كنت تتناول أيًّا من هذه الأدوية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المُستخدمة لعلاج عدم انتظام أو سرعة ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الأخرى المُستخدمة لعلاج الربو</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب ألا يُعطَى فينتولين حقن في نفس المحقنة مع أي دواء آخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>استخدام فينتولين حقن مع الطعام والشراب </strong></p><p dir="RTL">يمكنك استخدام فينتولين حقن في أي وقت من اليوم، مع الطعام أو بدونه.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين طفلك رضاعة طبيعية، أو تظنين أنكِ حامل أو تنوين الإنجاب، يجب استشارة الطبيب قبل استخدام<br />هذا الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">من غير المحتمل أن يؤثر فينتولين حقن على قدرتك على القيادة أو استخدام أي أدوات أو آلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يتم الحقن</strong></p><p dir="RTL">عادةً ما يتولى الطبيب أو الممرضة إعطاءك فينتولين حقن. ويمكن أن يُعطَى تحت الجلد أو مباشرةً في الوريد أو في العضلات<br />(عن طريق الوريد أو الحقن العضلي). ليس من المتوقع أبدًا أن تعطي لنفسك هذا الدواء. ينبغي دائمًا أن يكون من يعطيك هذا الدواء هو شخص مؤهل للقيام بهذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم تجهيز الأمبولات بنظام فتح OPC (نقطة واحدة للفتح) ويجب فتحها باتباع الإرشادات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمسك الجزء السفلي من الأمبول بإحدى اليدين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضع اليد الأخرى على الجزء العلوي من الأمبول وضع الإبهام فوق النقطة الملونة واضغط</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تحت الجلد أو الحقن في العضل</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 8 ميكروغرام لكل كيلوغرام من وزن الجسم كل أربع ساعات</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحقن البطيء في الوريد</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 4 ميكروغرام لكل كيلوغرام من وزن الجسم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم الحقن ببطء ويمكن أن يتكرر إذا لزم الأمر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن تخفيف فينتولين حقن بمقدار 10 مل من الماء المخصص للحقن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن إعطاء 5 مل من المحلول المخفف المُعد (250 ميكروغرام لكل 5 مل) عن طريق الحقن البطيء في الوريد</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يناسب فينتولين حقن علاج الأطفال الأقل من 12 عامًا.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حالة تلقي جرعة زائدة من فينتولين حقن</strong></p><p dir="RTL">يجب دائمًا إعطاء فينتولين حقن في ظروف محكومة بعناية. لذلك، إذا كنت تعتقد أنه قد تم إعطاؤك جرعة أكبر مما يجب،<br />عليك بإخبار الطبيب أو الممرضة في أقرب وقت ممكن.</p><p dir="RTL">قد تحدث الآثار التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبض قلبك بشكل أسرع من المعتاد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشعر بالارتجاف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط النشاط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم الحمض في الجسم مما قد يسبب زيادة سرعة التنفس</p><p dir="RTL">عادةً ما تزول هذه الآثار خلال ساعات قليلة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حالة التوقف عن استخدام فينتولين حقن</strong></p><p dir="RTL">لا تتوقف عن استخدام فينتولين حقن دون استشارة الطبيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أية أسئلة أخرى بشأن استعمال هذا الدواء، يمكنك سؤال الطبيب أو الممرضة أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل جميع الأدوية، يمكن أن يتسبب فينتولين حقن في حدوث آثار جانبية، إلا أنها لا تصيب الجميع. قد تحدث الآثار الجانبية التالية عند تناول هذا الدواء:</p><p dir="RTL"><strong>تفاعلات الحساسية</strong> (تصيب أقل من شخص من بين كل 10000 شخص)</p><p dir="RTL">إذا أُصبتَ بالحساسية، توقف عن استخدام فينتولين حقن، واستشر الطبيب على الفور. تشمل علامات الإصابة بالحساسية: تورمًا في الوجه أو الشفتين أو الفم أو اللسان أو الحلق، مما قد يُسبب صعوبة في البلع أو التنفس، وطفحًا جلديًا مصحوبًا بحكة وشعورًا بالدوخة والدوار والإغماء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>استشر الطبيب في أقرب وقت ممكن إذا:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعرت بأن ضربات قلبك صارت أسرع أو أقوى من المعتاد (خفقان). عادةً ما يكون هذا غير مؤذٍ، وعادةً ما يتوقف بعد فترة من تناول الدواء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تشعر بعدم الانتظام في ضربات القلب أو بزيادة في عددها</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تصيب هذه الآثار أقل من شخص واحد من بين كل 10 أشخاص</p><p dir="RTL">إذا حدث أي من هذه الأعراض لك، استشر الطبيب في أقرب وقت ممكن. <strong>لا تتوقف عن استخدام هذا الدواء إلا إذا طلب منك<br />الطبيب ذلك.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك إذا أصابتك أي من الآثار الجانبية التالية، والتي قد تحدث أيضًا عند استعمال هذا الدواء:</p><p dir="RTL"><strong>شائعة جدًا</strong> (قد تصيب أكثر من شخص واحد من بين كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارتجاف</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>شائعة</strong> (قد تصيب حتى شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلص العضلات</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائعة</strong> (قد تصيب حتى شخص واحد من بين كل 100 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى الذين يتم إعطاؤهم فينتولين حقن لعلاج الولادة المبكرة: سعال أو أزيز الصدر أو ألم في الصدر أو ضيق في التنفس، والتي قد تكون علامات على استسقاء الرئة (سوائل في الرئتين). أخبر طبيبك في الحال</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة</strong> (قد تصيب حتى شخص واحد من بين كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى البوتاسيوم في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة تدفق الدم إلى الأطراف (توسع الأوعية الدموية الطرفية)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>نادرة جدًا</strong> (قد تصيب حتى شخص واحد من بين كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في أنماط النوم وتغيرات في السلوك، مثل الأرق والاستثارية</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قد تحدث أيضًا الآثار الجانبية التالية ولكن معدلات تكرارها غير معروفة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لسع أو ألم عند الحقن في العضلات مباشرةً</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوعك والإعياء (الغثيان والقيء)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر، بسبب مشاكل في القلب، مثل الذبحة الصدرية. أخبر الطبيب أو الصيدلاني أو الممرضة إذا حدث ذلك.<br />لا تتوقف عن استخدام هذا الدواء إلا إذا طلب منك الطبيب ذلك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة تُعرف باسم الحماض اللاكتيكي، والتي قد تُسبب آلامًا في المعدة أو سرعة التنفس أو ضيقًا في التنفس أو برودة اليدين والقدمين أو عدم انتظام ضربات القلب أو العطش</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كنت تعتقد أن هذا الدواء لا يحقق نتيجة جيدة بدرجةٍ كافيةٍ بالنسبة لك</strong></p><p dir="RTL">إذا كان الدواء لا يحقق نتيجة جيدة كالمعتاد، فاستشر الطبيب في أقرب وقت ممكن. إذ يمكن أن تزداد مشكلة صدرك سوءًا وقد تحتاج عندها دواءً مختلفًا. لا تتناول المزيد من فينتولين حقن إلا إذا أمر الطبيب بذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ الدواء بعيدًا عن مرأى ومتناول الأطفال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يُخزن في درجة حرارة أكثر من 30 درجة مئوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تُحفظ الأمبولات في العلبة الكرتونية الخارجية لحمايتها من الضوء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُستخدم الدواء خلال 24 ساعة من خلطه بسوائل الحقن في الوريد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يُستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية، والمدون على ملصق الأمبول والعلبة الكرتونية بعد كلمة &quot;EXP&quot;<br />يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا طُلب منك التوقف عن تناول هذا الدواء، يجب عليك إعادة أي كمية غير مستخدمة من فينتولين حقن إلى الصيدلاني لإعدامها</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية برميها في مياه الصرف أو ضمن المخلفات المنزلية. استشر الصيدلاني بشأن كيفية التخلص من الأدوية التي لم تعد تستعملها. فهذه الإجراءات من شأنها المساعدة على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات </strong><strong>&rlm;</strong>‫<strong>فينتولين حقن</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعَّالة هي كبريتات سالبوتامول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكوّنات الأخرى هي ماء وملح (كلوريد الصوديوم) وهيدروكسيد الصوديوم وحامض الكبريتيك والنيتروجين<strong> </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل فينتولين حقن ومحتويات العبوة</strong></p><p dir="RTL">يتوافر فينتولين حقن في أمبول زجاجي 1 مل في علب بلاستيكية يحتوي كل منها على خمس أمبولات</p><p dir="RTL">5 مل تحتوي على 2,5 ملجم من سالبوتامول (على شكل كبريتات سالبوتامول) في محلول ملحي عادي معقم ومعدل لدرجة الحموضة 3,5</p><p dir="RTL">تحتوي كل عبوة كرتونية على 5 أمبولات</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تعليمات الاستخدام </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">المواد المخففة الوحيدة الموصى بها لـ تخفيف الفنتولين هي الماء للحقن ، صوديوم كلوريد للحقن ، صوديوم كلوريد و الدكستروز للحقن أو الدكستروز للحقن (حسب دستور الادوية البريطاني) .<br /><br />يجب التخلص من جميع المحاليل المخلوطة غير المستخدمة من فينتولين للحقن بعد 24 ساعة من التحضير.<br /><br />لا ينبغي أن يستخدم فينتولين للحقن في نفس المحقنة مع أي دواء آخر.</p><p dir="RTL"><strong>ڤنتولين </strong>علامة تجارية مملوكة أو مرخصة لمجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&copy; 2019 جلاكسو سميث كلاين، جميع الحقوق محفوظة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>تصنيع:</strong></p><p dir="RTL">جلاكسو سميث كلاين مانيوفاكتشرينج إس.پي.أيه*، پارما، إيطاليا</p><p dir="RTL"><strong>الشركة المالكة لرخصة التسويق</strong></p><p dir="RTL">جلاكسو سميث كلاين مانيوفاكتشرينج إس.پي.أيه*، پارما، إيطاليا</p><p dir="RTL">*عضو في مجموعة شركات جلاكسو سميث كلاين</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            نص رقم: المملكة المتحدة 6
تاريخ الإصدار: 29 اكتوبر 2014

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ventolin Injection 500 micrograms (0.5mg) in 1ml
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ventolin Injection 500 micrograms (0.5mg) in 1ml (500 micrograms/ml) is presented as ampoules of 1ml, each containing 500 micrograms salbutamol as salbutamol Sulphate BP in a sterile isotonic solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                A colourless or faintly straw coloured solution for injection.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ventolin Injection is indicated in adults and adolescents.</p><p>&nbsp;</p><p><strong>RESPIRATORY</strong></p><p>&nbsp;</p><p>Ventolin Injection provides short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. It is indicated for the relief of severe bronchospasm.</p><p><strong>&nbsp;</strong></p><p><strong>OBSTETRIC</strong></p><p><em>&nbsp;</em></p><p><em>VENTOLIN</em> is a selective beta-<sub>2</sub> adrenoceptor agonist.&nbsp; At therapeutic doses it acts on the beta-<sub>2</sub> adrenoceptors in the uterus, with little or no action on the beta-<sub>1</sub> adrenoceptors of the heart.&nbsp; It is indicated to arrest uncomplicated labour between 22 and 37 weeks of gestation in patients with no medical or obstetric contraindication to tocolytic therapy, under the direction of a physician.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ventolin Injection may be administered by the subcutaneous, intramuscular or intravenous route, under the direction of a physician.</p><p>&nbsp;</p><p><u>Adults</u>:<em>&nbsp; </em></p><p><em>&nbsp;</em></p><p><em>Subcutaneous route:</em> 500 micrograms (8 micrograms/kg body weight) and repeated every four hours as required.</p><p><em>&nbsp;</em></p><p><em>Intramuscular route:</em> 500 micrograms (8 micrograms/kg body weight) and repeated every four hours as required.</p><p>&nbsp;</p><p><u>Slow intravenous injection:</u></p><p>250 micrograms (4 micrograms/kg bodyweight) injected slowly. If necessary the dose may be repeated.</p><p>&nbsp;</p><p>The use of Ventolin Injection 500 micrograms in 1ml (500 micrograms/ml, for intravenenous administration may be facilitated by dilution to 10ml with Water for Injection BP (final concentration of 50 micrograms/ml) and 5mls of the diluted preparation (250 micrograms/5ml) administered by slow intravenous injection.</p><p><em>&nbsp;</em></p><p><em>Paediatric Population</em></p><p><em>&nbsp;</em></p><p>The safety and efficacy of Ventolin Injection in children under the age of 12 has not been established. From the available data no recommendation on posology can be made.</p><p><u>&nbsp;</u></p><p>Children aged 12 years and over: Dose as per adult population</p><p>&nbsp;</p><p><u>Instructions to open the ampoule</u></p><p>&nbsp;</p><p>Ampoules are equipped with the OPC (One Point Cut) opening system and must be opened using the following instructions:</p><p>&nbsp;hold with one hand the bottom part of the ampoule as indicated in Picture 1 put the other hand on the top of the ampoule positioning the thumb above the coloured point and press as indicated in Picture 2</p><p>Picture 1</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4REARXhpZgAATU0AKgAAAAgABAE7AAIAAAASAAAISodpAAQAAAABAAAIXJydAAEAAAAkAAAQ1OocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEh1c2FhaW4gQWxtYWtyYW1pAAAFkAMAAgAAABQAABCqkAQAAgAAABQAABC+kpEAAgAAAAMzMQAAkpIAAgAAAAMzMQAA6hwABwAACAwAAAieAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMDoxMjoxOSAxOToyMzoyNQAyMDIwOjEyOjE5IDE5OjIzOjI1AAAASAB1AHMAYQBhAGkAbgAgAEEAbABtAGEAawByAGEAbQBpAAAA/+ELJGh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMTItMTlUMTk6MjM6MjUuMzA4PC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkh1c2FhaW4gQWxtYWtyYW1pPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAPUAsAMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooooAKKKKACiiigAooooAKKKKACiiigDO8Qa5aeGvDt9rOpFhbWUJlfb1bHQDPGScDn1rAsfFOvW+oab/wkuk2FtYavIIra4sb4z+RIVLIkuVUHcAQGQkbsDuDS/EozT+G7TTbNYXutS1O1ghS4BMbFZRKwbHO3bE2fauQufDgsfFfhuSbwda6Nu1hCbiy1EyQFhHI2FhwoGSoOdvFAHr1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHnfjQaPrHi4R+JmjXQPDVg2oXzyMQonlykXTkMqLK3HOWTFYtnfeHNZtfD3iPwpr2ranY2+uw2zQ3d3LIsLOGj5WT5s/vFwST1rb8SaDpeoeJvEGja5crHpniPSUnuGMoRrd4HWMMCeAD5kZGe6HrmsbTfh9pPhDRdP8AA/hmWe8m1e/TUbu9lcExQW8kbs+VGByERQO7k9jQB65RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVyniHxFqM+sjwx4QET6u0Ylu7yZd0OmRNna7gfekbB2R8Zxk4UcgGrr3irRPDEKSa7qUNoZTiKMktJKfREXLMfoDWGPGHiHVD/AMU14MvHhPC3WsTrYofcJhpcfVBWl4e8G6Z4fmkvR5l/q04/0jVL0+ZcTe27+FfRFwo9K25bmCGWKKaVEeZisSs2C5AzgepwCfwoA5RR8SZmLM/hWzXsnl3Nwf8AvrMf8q5vx34r8ceDNKtLifUvDslxdTiGOCLTZst6nJn7cD3LKOM5rtL7WWe2tpUL28kOqx2k8e71fbg+oIZWH1Fch4x8ZeEbH4oWVj4mvrU29npVys8TxGcK8zw4V1VTjKIx+bsaAJLLwp46065vr26l8O+I7nUVVbptQjmgbywSVhUDzECDc3AXkkk5JrM1PUde8E6tputyeB7Ww02ySW0uotJvopFkjlZX/dxlYz5gkQEKB8wZh1Ird0G20nVIW/4Vv49eOBFz9ijmjvYoR2+STLoPYMB6Crmo+E9Xv7Nh4n8WzXOnwslxJb2ljFbiTy2Ei7mO5sblB+UigAsviz4WuIbeTUZ7rRPtKK8R1a0e3R1YZUiUjyyCO4Y12NvcwXdulxaTRzwyDKSRMGVh6gjg1zvgKyVPhloNtdRrIr6fEzRuuRhlDbcH0zj8Kz7/AOHkenSSal8P7j/hHdTzv8iLP2K6P92WD7uD03KAwznJ6UAdtRWH4Q8SL4p0Bb1rdrO7hle2vbNmy1tcIcPGT3weQe4IPetygAooooAKKKKACiiigAooooAKKKKAMTxb4h/4RrQHu4YPtd7NIttY2gbBuLhzhEz2GeSeygntTfCPhz/hG9F8q5n+16ldSNc6jeYwbidvvN7KOFUdlVR2rDs3PjL4ktqCNu0Xwu0lvbkfduL5l2yOPURISn+87+ldzQAVV1LTbbVtPks71C0T45VirIRyGVhyrA8gjkEVZDBhlSCM44paAPE/EniXVNC8RJ4dnC3euzTW00DSZjju1gk3i5cgYUeUCHwODAccEV0XwnvLxtPsoJ4ITNqFg2ualcBcM8t1OzRD6bFcc54VR2rF+Mc6trl0yxqJNP8ADVwomI5jN5PHbhs+yiU/nXp+k6BbaNd3M1qTieOGFUxxHHEm1VH5sfxoAxvGngvStV0241S3SPS9bs42ntNXt0CSwOoJBZh95OMMpyCCa88l+MGtaj8O2uNY8KzxW2q2Jgh1S1Y+SJ5UKopVwDjceSpYCvRfijetZfDPWVhz595B9hgC9TJOwiXH4vn8K8t1XToLews/AsaFbCLx0lvFCGPy25iW42gjkD96aAPd7G1Sx0+3tIvuW8SxL9FAA/lVXWvEGkeHbFrzXdStrCBRnfcSBc+wHUn2HNeb+NfAGh+HfsviFYdTuNItpCNWtP7Vu22wtgfaF/eZzGQCQOChbuBXZaJ8P/BulTx6jo+h2JnYB47xl858dQVkck/iDQBV+G9rdHTdX1q9tpLQ69qkuoQ20q7ZI4SqRx7x2YrGGI7bsdq7GiigAooooAKKKKACiiigAooooAK5Pxzrd7BHa+HfDj7de1otFBIBn7HEP9bct7IDx6sVHrW/rGrWeg6Ld6rqkwhtLOJppnPZQM8ep7AdzXO+BtIvJPtPivxFEU1vWVU+S3P2G2BJitx6YB3N6uT6CgDf0LRLLw5oNnpGlx+Xa2kYjQE5J9WJ7sSSSe5JNWry7hsLOW6un2QQoXkfaTtUdTgVNRQBymjXaab40v8ATDMrWesINU02QNlXOAs6Ke+Dsk46+aT2rZ8Qa9Y+GdButX1WQx21sm5toyzknCoo7sxIAHckVxPinwnqmlQCXwzHJc2MNwLy2tocefpc4zmS3DEB4mBYPASMhmCkZxWbpOqzeLdGj+I/jVIrTRNGhkutP0uKTeDLGCGuJM9XyGVEP3f96gCX4b2F/wCJtX8bal40gilkv5IdOlsj8yW8aw7zb++3zwrHuwY1tQ+GfGvhqIW/hTxBZalp0YxBZa9C7PCvZFuIzuIHQblYgdzVvwTaXXhv4dQ3WqW08+pXRfUb6G3j3SGedzIyhe5Xdt+i1sWPijTb24S2kM9jdyfct76BoHf2XcAG/wCAk0Ac3D4a8WeI9c0y98c3GkwWGlzi7g07S/MkE04BCPJI4HC5JCgdcEniuIV01P8AaaWzQfu7bUZrtsf3ksIEz+ZxXufTrXzb4X8RJZ/EXWvFa27XlxcW00unWoYBrmW6u9lugPuiJz2GT2oA+kJI0miaOVFeNwVZWGQwPUEVw/g15PCfiK58C3bs1okZvNClck7rbdh4CT1MTEAc52MvpXbwmU28ZuAol2jeEOVDY5xntmvI/Gs/ibSxp+s63bof7H1OG4tryIKSI5JVikiZlxw0ch4KjlRyTQB6/RRRQAUUUUAFFFFABRRRQAUUU2R1ijaSRgqKCzMTwAO9AHEa+B4w8fWfhkfPpejCPUtWH8Msuc20B9sqZSD2RPWu5rivhXE9z4RbxDdowvPEV1LqcpY5IR2xCv0ESxgCu1oAKKKKACvIdX0C4f4tDwjZqB4f1iSLxDfw4G1GhciRAP7skogY+4b1NevVxXhAjWPHfizxAfnjiuI9HtGI6JAu6THsZZHH/AB6UAdNq7aqlqkmhpayzpIC8NyzKJU5yquM7W6YJBHGMc5HORHULgPZ6/p99eWM5+a3u7WKR4yem2SJtpAPQlQR1zkV2VFAHKfEDUJdA+G+o/2e0jXkkC2Nlucs7TSkRR8nknc4OfY15j8OvC1tdfHrW5ohv07wpbW9jbg9DMsIhVj6kKkn0LV1PxA8V6RB8TPDeiatcOIdPR9Ye3hgeaS5mGY7eNFQElsl3x/sLTfgfE72/jDULtVS8vPEU7ToGDeWdiN5ZYcEqXKnHcGgD1KuH+Kp+06Ho2kDn+1tdsrZh/sLKJW/8diNbPjDxMfDGjRTW1ob/ULy4SzsLMPs8+dz8oLfwqACxPYKa4lR4u1D4t+FbLxiuihLOC71KNNLaU4YIIcPvHODNwR1544oA9VooooAKKKKACiiigAooooAK5T4nXc9r8ONWjs223V8iWEBzjD3DrCCPp5mfwrq6474gA3N34S09eTc+IIHYf7MKST/AM4xQB1VjZQ6bp1tY2iBILaJYYlH8KqAAPyFT0UUAFZPiJZ7jw3dvprsbiEedD5Tcu8bB9nHqV2ke5Fa1c3q2iXthcyax4SKR3hbzLnT3bbBf+oP/POTHSQd8BgR0ADxR4th0bwLJrtgBdS3ESLp0Q5+0zS4EKAe7Mv4ZParPg7w/wD8Iv4Q0/SGk86aCLNxN/z1mYlpH/4E7MfxrhPAtm3izxIdUUSr4W0K6lbR7aeIo32mRR5u4ZwVhLSRp6FmwflBr1agAoorl/iVqsmi/DPXry3bZP8AZGhhbONskn7tDn2ZxQByPg/Q9O8cahrPiW+1TUEl1a4MkdnZ6hJbhrFGaG3LqhBIbypGHODuNbfgGztvD/i7xh4csrZLW2hure+tYo1CqIpYFT5R6B4XFQeGLW20D4nf2LaOrwf8ItZpbspzkW8siN/6NQ/jWl4s0rUrHXbTxf4bt/tl9ZwNa3tgCA17alt21SeBIjZZfXLDvQBBqWdW+M2lWu0vDoOlzagwHTzpm8mPPvsWbH1rI8FaZPZfEmKC73fadP8AC0C3AY52zT3Ekjj80qTUPEPgHxRu1JPFKeG9bgQRtO9yLK7g2kkJLFJjeoJPyupXk465qH4Q6o3iHXvGGtTahZajM11b2P2myBEcyQxcSBT0DF2PUjOcEgZoA9QooooAKKKKACiiigAooooAK47XR9r+LPhO2Uj/AEO1v75x/wABjhX/ANHNXY1xunlb/wCNGszjkaXo9rajno00kkjfokdAHZUUUyWJJ4XikGUcbWAJGR+FAGdfeJNJ06fyLi73zjrBbxtNIPqiAsPyrkvEvjCfW5YfCfhaPULPWdUGHuLmzlh+x2vSW4G4DkD5V/22X0rqNY1XSfBfhye/njW3tYB8sNvGN0rnhURR952OAB3JrN8EaFfWqXev+I1A17WWWS4QNuFpEB+7tlPogJyR1YsfSgDe0fSLLQdFtNK0uEQWdnEsUUY7ADue5PUnuSTV2iigAriPifCmoWfh3Rp4knh1PXrWKeFxlZIk3TOCO4xFgj3rt64rxFm9+LXg6zQ7hZw32oSr6ARrCp/OY0AZuveBtP8AB89p4r8CaDBBeaZKz3lnYxBGvbVlxJGFHBYcOo9Ux3q/Y+JLrxv4ohXwtemLw9phSW9vkQE3kxUMtsm4cKoYGQ9ckLwc1oeOtcvNN0220vQiv9u61N9jsM8iI4zJOR/djQFvrtHetXw7oNn4Y8P2mkaarCC2TbuY5aRjyzse7MxLE+pNAGZ42S3tNGfVD4ftNXuLdlJNxCr+WmcsxJBYADuAcZzggGsfwpe2l/8AE3VrvSlVLW60OwlljVQPLkEtwoVscbgBj8PTFd9XB/C62gurfWfEttEkVvq96UskQYVbOD91Dgds7Xf/AIHQB3lFFFABRRRQAUUUUAFFFFABXG+AAbvUPFurOMtea7LEjeqQIkA/WNvzrq727i0/T7i8uDtit4mlc+iqMn9BXNfC60ltPhfoRuc+fc232yXPXfMxlbPvlzQB1lFFFAHIQeHtR1vxw+t+J0RLLS5GTRrBXDru6G7kxwXI4UfwDPc8dfRRQAUUUUAFcTouNQ+Mvii8fk6ZYWenxH+7v3zv+e6P8q7auK8AuLnVPGepsMCfXpIQT3WCKKH/ANCRqADQx/b/AMU9d1h/nttEiTR7PngSMFluG+vMSZ/2DW54j8WaP4UtoZdaujG1w/l28EUTSyzt1ISNAWbHfA471h/Ckj/hWtpqlztSTVJbjU53JxzNK8mSfZSo/CovAkB8S6neePb9CTf5t9HRx/x72Kn5WAPRpSC59ig7UAQ+JvHVnrXgaWPwdeedqerXA0i1VkeOS3nkHzF0YBk2Juc5HRfetb4Z3aXXw30dEt1tWs4TYywKciOSBjE4HtuQn8a5ZZLO5+NWo+K4NNWex0iKLRri9UgbLhiTJKB/FsDRxseCAzdQpFb/AMKN03gNdRKFE1S+vNQiUjBEc1w7p+akH8aAO0ooooAKKKKACiiigAooooA5H4p3EsXw01e3tsm51CNdOgUdS9w4hGP++8/hXU21vHaWkNtAu2KFFjQegAwK5Dxn/wATLxl4O0Mfda+k1ObHZLaPK/h5skX5V2lABRRRQAUUUUAFFFFAFXVNQg0nSLzUbtttvZwPPK3oqKWP6Cue+GenzWPw10hb5SLq7ia9uQw58ydjKwP0LkfhVX4ludR07TPCkLHzfEV8ltKFOGFqn7y4b6bE2/8AAxXQ+JNWXw54S1TVhGrLp1lLcCPoG2IWC/jjFAHBeFIotV+HmufDJ9RW11nSYJ9MchgW8lgfJmAB5UoyZ7g5BxxT5fiDc+HvCtxoN5pUem+LLOCK10/To3DQ3jufKhkgPG6PcMkHBUAg+pltfAfhmz+Gtnd+NoVkurSCTUb7UhI0UyzSDzJnEkZDckkYB5AUY4rmPDvwj0u60u68baxc6pod/MjXenv9ukaXS4AuUZ2diWcr8zhjgZK4GDQB0Gq6W+j+FNI+GOg3LPqmrRN9vvFPzxW5Obq5b/admKrn+J/9mvSrOzg0+wt7KziWK3t4liijXoiKMAD6AVxPwp028n8Op4t8QyfaNd8QxR3E8mzaIodv7qJF/hUKd2O7MTXeUAFFFFABRRRQAUUUUAFFFBIVSWOAOST2oA4zTP8Aia/GLWr3rHounQadHxx5kp86X/x0QV2dcX8LQbrwxea6+d2vanc6guf+eZfZF+HlRxn8a7SgAooooAKKKKACiiuT+IGtXllo8Gj6DJt13XJfsdiRyYcjMk59o0y312jvQBU8Mk+KPHureKW+aw08NpGl+j7WzczD6yKEBHaI+tVPiHDN43vB8P8ATLl7dJ4DdavdR9beDnyo/wDekkA4/uI/qK2dRu9O+G3gO1tdMtWm+zpHY6bYoRvupzwiZ9WPLN6bmPSrHg3w3J4e0mR9SmW71nUJTdandgf62Zh0X0RQAqjsFHqaAPO9c1648R+E9N0i8axj1bRbmJ9d8P3tyttJfeTghYmb5WjZgrg/dYYBI5rWv/EVl8WJdM8PeHZml0e5hj1DW51ODHBnKWpx0eRlwwzkIrdc13mr+GtD8QBBruj2GpeX9z7XbJLt+m4HFP0jQdJ8P28lvoem2unQyyGV47WFY1Zj1JAHXgUAX1VUQIihVUYAAwAKWiigAooooAKKKKACiiigArmPiPqc2l/D7VXs+b26iFlaKDyZpmEUeP8AgTg/hXT1xXiQDXPiZ4a0PhoNNWTW7pSO6/uoB/327t/2zoA6jRtMi0XQrDS7b/U2VtHbpx/CihR/KrtFFABRRRQAUUUUAR3FxDa20txcypDDCheSR2wqKBkknsAK4nwar+ItYu/H2pIYLe5g+z6PFNlTDZA7jKwPRpWw3sqoM9ag1Sf/AIWVrz6Bp7k+GNOm/wCJxdIflvZV5Fojd1BwZCPZe5qx4ud/E+tQeA9OYx2skIuNbmiJHlWmSFgBHRpSCPZFc9xQAnhhG8aeJj40u1b+zLVXt9AhdcZQ8SXePWT7q/7Az/HXdUyGGO3gjht41iijUIiIMKqgYAA7DFPoAKKKKACiiigAooooAKKKKACiiigArivh/wD8Ti/8QeLWO5dVvTb2ZzkfZbYmJCPZn81/+BitXxzcarB4Mvk8PQSTancqtrbmNSfKaVgnmnHQIGLk/wCzWlouk22g6DY6TYgi2sbdLeLPXaqgAn34oAvUUUUAFFFFABTJ4Y7m3kgmXdHKhR1zjIIwRxT6KAOe1S90n4feCy9nZLFaWaLDaWNsuDNIx2xxIO7MxA+pJPem+CvD9zomkS3GsOk2t6nKbvU5k5BlIACKf7iKAij0XPc1lBR4w+JzO3z6T4UO1R1WbUHTk+h8qNgPZpT3Wu4oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKxvFuvjwx4VvtV8ozywoFt4B1mmYhY4x/vOyj8a2a4rXMeIvibo2iD57TRY/wC2L0Y4MpJjtlPvnzZMf9M1NAGx4N8Pt4Z8KWmnzy+feYaa9uP+e9xIxeV/xdjj2wK3aKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuW8GaTeW974g1nV4DDfatqTsqsQStvF+6gHHHKqX/4Ga6migAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP//Z" alt="" width="176" height="245" vspace="0" hspace="0" border="0" style="width:176px;height:245px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>Picture 2</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4REARXhpZgAATU0AKgAAAAgABAE7AAIAAAASAAAISodpAAQAAAABAAAIXJydAAEAAAAkAAAQ1OocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEh1c2FhaW4gQWxtYWtyYW1pAAAFkAMAAgAAABQAABCqkAQAAgAAABQAABC+kpEAAgAAAAMyNAAAkpIAAgAAAAMyNAAA6hwABwAACAwAAAieAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMDoxMjoxOSAxOToyNTo0OAAyMDIwOjEyOjE5IDE5OjI1OjQ4AAAASAB1AHMAYQBhAGkAbgAgAEEAbABtAGEAawByAGEAbQBpAAAA/+ELJGh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMTItMTlUMTk6MjU6NDguMjM4PC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkh1c2FhaW4gQWxtYWtyYW1pPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAQ8A3wMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooooAKKKKACiorq7t7G1kur2eO3giUtJLKwVVHqSelctJ49+0RGXw94d1jWoMgLPbxLHHIPVWkZdw9xQB11FcT/AMLV0Ky1SDTPE6T+Hr24UNHHqG0Kc9t6kqD9SK7SORJY1kidXRwGVlOQwPcGgB1FFFABRRRQAUVUvNX03T2C3+oWtqT0E8ypn8zUEfiTQ5XCRazp7sxwFW6Qk/rQBpUVFFdW87bYZ45D1wjg1LQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFMmmjt4JJp3WOKNS7uxwFAGSTT65TxazazqWn+FICdl4TcagVP3bVCMqf8AfYqv03ehoAq6dZf8J7NHretxE6LHJv0rT3GFmAPy3Mo7k/woRhRyQSeNXxprVzoHheV9IgE2p3LLZ6dBjhp5DtTPYKvLHPZTW+qqiBEUKqjAAGABXnvxGs9b1zxFoWl+GNQWwv7SO51NJZIt8ZdFWJFb0yJZBnkjGcUAHgy20GIyeHtc0U2viGaMy3g1JFmfUOMNMsvKyA56DBXONoq3NYS/DuZLzRkmk8MEkXWmRIZGsyTxLCBzsH8UY4AOVGcg0vC2laLr2sLJrT6nN4j0OQNJbalclmt3Ix5kYXAZG5wwGD0ODxXotAHL6f49sNT8S2ujWmnasHuYZJkuJ7FoIwiBct+82tjLqAQpGTXTkhVJYgADJJ7VyPg9f7a1rV/FcwUrdSfYtPIOcWsRIz7b5N7fTb6U7xQW8Q63a+E4nZbaRPtWqtGxB8gHCxZHTe3X/ZVh3oAsReLzq/mDwppk2rIjbReO3kWhIODiUglwMdUVh71nw6P421e82+JtS0+005yd1vo8sqOB2HmkBifUjaOvFdnFFHBCkUKLHHGoVEUYCgcAAdhTqAOfsvAnhixdZItFtJJlOfOnj82QnGCSzZJOKmuPBvhq6mWa40DTXkQYVzapkfjitqigDm5fh34RmuDcSeH7EzEYLiPBx+FQp8NvC8N49za2EltI67T5FzIgxx2DY7V1VFAHLSfD3R3uY54rnVreSMYUwapPH+gfmpk8F28TB4tZ15XH3S2rTOAf91mIP4iujooA51fCtyrA/wDCTa0cHPMyH/2Srk2kXs0LRtr18oYYzGkKsPoQnFa1FAEdvE0FtHE8rzFFCmSTG5sdzjvUlFFABRRRQAUUUUAFFFFABRRRQAVzHhLOpajrevvkrd3ZtbUnP+ogJQH8ZPNbPcFa0vFGq/2H4T1XVAcNZ2ksydOWCkqBnuTgU7w1pY0TwtpmmA7ja2scTP8A32Cjcx4GSTkk+poA065hEMnxYnZnbEGixbEz8uXnk3H6/ItdPXNQn/i6t7/2Bbf/ANHzUAWPEvheLXxb3Nvcyafqlk2+0v4R80Z7qw6Oh7qeD7HBrl9W8Yam+kT+G9Stf7N8T3kgs7YRNmK4R22m4iY9Qqkkg8qRz2J9FqOS3hlmilliR5ISTG7KCUJGDg9uDigCnDFZeGvDiRgiKy062wWPZEXkn8BWT4Is5n06fXdRQpfa3ILp1brFFjEUf4JjPuWpni8/2tfaZ4VjAZdRkNxfZPC2kLKXU/77FI/ozeldTQAUUjMFGWIA9SaytX1WTSdR01pQv2C6m+yzOescj48o/QsNmPV1PQGgDWqK3uobpXNvIH8tzG+P4WHUGpa5nTWax+IWr2I/1N7bRXyKBwHBMbn8cJ+VAHTUUVUk1COPWbfTirGSe3lnVgOAI2jUgn1PmDH0NAFuiql3qthYMFvLuKJzyEZvmP4dat0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcx4/Zn8OQWaEKb7ULW3JL7flMys4/FVYY966YlUXLEKB3JrE8V+F4vFWn2ttLe3Ni9rdx3cU9qQHV0zjGQR3PaqUXw90YuX1OXUNXkIxnUL2SQY5/gBC9z2oAval408N6TMIdQ1uyimP3YfODSNzjhBkn8qxNLvl1z4lpqmn6ZqSWiaW1u97dWklujHzFZVUSAFs5Y5AxxXU6do2maRH5ek6daWKYxttoFjH/joFXaACmySJDE0krBERSzMxwAB1NOrk/Fry63qFp4TsnwLoC41N1bBitA2CvsZG+Qewc9jQBJ4PjfU5L3xRdKwk1RgtqrDBjtEyIh7bss5939hXUU2ONIo1jiVURAFVVGAAOgAp1AFXVNOh1bS7ixuS6xzptLIcMp7MD6g4I+lc7AB4s8N6l4c13EepWy/Z7rYCPm6xzpns2AwPYgjqDXTXklxFau9nAtxMB8kTybAx/wB7Bx+VeY+LvEc+n3EGuXNnceGtbsl8uN7pTNZ6hGeTbtJGDjLfdJCkN0ByRQB2ng3WrnVtFaDVQqavp8htb+MdpF/iHsy4YezVXtSJvipfsZCWttKhjCY4AaRmz+lcZfa9qVxrFv4q0TT5vDDeUsWqyeIQsNrcJtyigAl3kBICsAOCRzwKu6H4n8W6vrEt9beAo1aSHyE1OW+aGORQcg+W6B8ZOfug+9AHpVzcw2drJcXUqQwRKXkkkbaqqOpJPSuRtPt/i++fUrQXGi6W0fkxzsu26vEBzuUH/VRnJwcb24PygDNmPwpd6tdpdeMb9NQWNt0WnW6GO1Q5yCykkyEY43cD0rqaAM/TtD07SyWtLZRK335nJeRzjGSx5NaFFFABRRRQAUUUUAFFFFABRUVxdW9oge6njhUnAaRwoz+NS9elABRRRQAUUUUAFFFFABRRRQAjMEUsxCqBkkngCuJ8BajBdpeave+bHea7cfaYmmiKg2/3bdFPQ4jwcf3mb1rsby2F5Yz2zMVE0bRlh2yMZ/WsLwHI8/gjTVu23XMEYguIioHkTR/I8Yx/dZSOcn3oA6OiuM8U/Eez8M3F8gsJr2PTI0l1CVJ4oxAGBKqA7Au5UZ2r7dzU1t40u9ftI5/CGg3N9BMgaO9vm+yW/P8AvAyH/gKEcdaAOtry7W/FCeJ/G0en6Rbf2tDpEuYrVG+S4uwceZI3RYYvU9XI2g7a3tW0bxBqWk3beJfEa6fp/ls09volsUk2DJI85izHI67VU9h61oaXpeheBPDSjQtKNvYAiSXyEy4B6yPk7mwOT1NABpXhXbfLq3iO4Gq6v1R2BENqP7sMZOF/3vvHue1dHTYpY54UlhdZI5FDI6nIYHkEGnUAFFFFABRRRQAUUVHPcQ2sDz3MqQxIMtJIwVVHqSaAJKhuru3sbV7m9njt4Ixl5JXCqv1JrnP+Eun1rzIfBtg1/jgahcZis1P+996T6ICPUjrUtp4QSe5S98U3ja5extviEsQS3tz/ANM4RkD6sWb3oARPEGp65uHhjTwtuCR/aGoBo4290T7zj34HvU6+Gp7mQS6zreoXbYH7q3lNpErDHIEZD9ujOw5reooAzLHw3oumzCay0u0inAA88RAynAxy5+Y8eprToooAKKKKACiiigAooooAKKKKACvP9evr7QPHX/FG2Z1a91CMSanpYfYiAKVjuPMPyxtldpB5cDgZXNegVzPhlkHirxhE2fO/tKGTLDkxmzgC8+m5ZPxzQB5JBB4jtfE2vatqth4M1DVxGJ7uPU9S3SQ7IV4RdoRUUkDLc8kF+9eqfDnxBa654XVIppDeWsjJd285HmQuzFgDjjaQwKkEgrjBPWoG1TUrDTZbmwgZmmmmkdprJiWlMu1Igqc9ARuPbBzWbocNvb/G7VorZcXH2HzrnZGVAWRgUDnJDEEPj0yaAOh8YvNPbx6SqqY9UimgUsvCzBC0eWyMZIxjvWpoV/Dq3h+zu4+UmhG5WXBBxhlI7EHIIq5cW0V1F5c6bl3BsZIwQcg5FctNr+geGtcvre0nuLm5nYzT6bYW7XBikPLOQgOwtkEhiMnkck0AX/Cwjsm1PRopN6addbY15/dpIokVOR2DY71v1w9p46sf7VnFj4R8Sm4unDSS/wBmlFlKrgEszAfdUDnHSk1rx7rGmW0EyeErqGKeaO3WW+uY4wkkj7EBVSxIyRn0zQB3NUdW1vTNCsmu9Yv7eygUcvNIFz7Adz7Dk1w/iKTxY2qaRpdz4ltdMk1Odty2Ft9yGNS8jeZJnnGAOOpzVOPS9E1LUo9YszCmiaZOlzeeIL+UyS3bxNvCwu5+WMOq7mGA2MAY5oA3tI+Illr8a6jY3On2WioGZ7q+u0EjgdcRhvkGOcuQR3XvV0/ETw3Kxj0q9fWZgceVpUL3R6Z5KAgD3JArK8P6DY+KvENx4x1LSIFgmi+z6dDcWyhnizkzuCM7nIGM8hQPWu7VVRQqAKqjAAGABQBzDaj4t1Ztmm6RBocBHNxqkizS9+kMTFfTkyfhTofBNrcSrceJLu4124Uhh9rIEKEf3Ylwo/EGumooARVVFCooVVGAAMACloooAKKKKACiiigAooooAKKKKACiiigAorN1zXbTQLAXF2JJHkcRwW0K7pbiQ9ERe5P5DqcCsKLSvFOvMZ/EOqf2JZnldO0th5gX/ppcEZzjqI9oH949aAOnvNQstOh83ULuC1j/AL88oQfmTXmninxlo2jeJB4h8N+INLmu3tBFeafI7lLyMMfKZXjDbXDFlBIOQ+OOK6geA9AtLOW4sNOju7/aZIbi8c3EjuFwvzyE8cAfiayvFv8AYd7p3hqOZbe30/U7kFpAVhTyxA78njHC8e+KAODt/iD4z8m41a30wWlvq0huJrW1ge5urULGiAIHCRkttLd8E8g03wx8QpPDuoahaDR7mPUNUm+1jUNfciWRCpwriJGJKlDhVAGPTFelaDqSXKLaeHvG2malDGPKjSaBJZFwMgZjdAcDHbOO5qHxToFzFpn9uX+oy32o2PlGBY4lijDCaNjhV+Y524wWPDNjGaAOU07xrpHiHUTY+PfFslhPIcpptsXsrZ0PQGbh3+hZe4K16tpNnpOn6ZGNDgtLeyK7k+yqqxsPXK8H61Pc6fZ3y4vbSC4BGCJYw3H415v4u8BaFoV1p+uadp8YtI7xIbzS2b/R5I5mVC6Rk7UcHacrjOCDnNAF3xT4xsrjxZaaBHrsllZNaSXFxcaYwkmkdWVRCCoYx9SScAnjBGDnC17QdD1vRbuLTvDV9DNNGP8Aifa4X/0NM7vNWSdi4IHIxznHSuzj+G+iWEhk8PSXmguz72Gm3BjRj3zGcoc/Spo/A9tPLDJr+p6hrvkNujivpF8oMDkMY0VVYjsSDigDntT0Q/FVoPN+16ZoNkW+z30RCXF/uXadoYECEgnIYHfxxiuisPAWkWrW7Xsl3qhtcfZ1vpt0UOBgbYVCxjHY7cj14FdMAAAAMAdAKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigApskiRRtJKyoiAszMcAAdSTTq5TxrNLqYtvCmnti41bIunB5gtB/rH/H7g92oAZ4WtpNd1OXxfqSczgxaVE3/Lva9mwejyHLE9cbV7V1rKHUq4DKwwQRkEU2GJLeCOGJdscahVUdgBgCn0Act4h+1aDZi6sVBsICJNgODbsPx5jYZUj+HIPQYHk1p4gl1Oyj1rVNKs7iHSra1t9Hs7yNmhPnSyfvioXG/wAqNCBzhWHI3EV7T4xu1sPA2uXUgQrDp877ZD8rYjbg/XpXG6bBoXh7Uxp3ij7Pa2zWtlJYTT/u4GaOIxkBuFDDH3SehBHsAdfqnhfRtV0ho9R0u1VhECHjQI8JUcFXGCuO2DXk2l+NNdHhvS9UutbbX7W5v4bN7BLVY5UkWaMA7yfmZsg9Qp3du3o3iXx3okHh+6j0nVbPUNSuI2hs7SznWaSaVhhQFUnueSeB3ryzXtPXw34v0rw9ERsjm0acoq4AZZoomP47M8fWgD0w+P8AUp9cOi2XhC/i1Ap5ka6jcQ28bx92DKz7scZCgkZGcVZh8Pazruo2l94wnt44bKbz7fS7Es0W8H5HldsGQrwQAFAPODWj4o8MW/iWxjUzPZ39q/m2V/D/AKy2k/vD1B6FTwRxTfDGvy6qt3YanEtvrGmyCK8hU/K2RlZU9Uccj05B5BoA3qKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAgvr630zT7i+vpVhtraJpZZG6KqjJP5Cue8G2M1x9r8T6krLe6yVeKKRcG1tRnyYvY4Jdv8AacjsKh8U48Q+INP8Kp81txfamOxhRvkjP++4HHoh9a67p0oAQnCk4zgdBWHZaqkWptA8pe2unJgkY/6qT+KFv7p7gd+fSt2sLXvCOna9BcLL5ttNcJsknt22sw7ZHRsdRkcGgDg/i9fP4m8P6x4f0+Z4rGzjX+0LuMk5nZlENuBj5sswZsdAB616gEhWzhiuxGQFAxJjBIHvXlPh6ESXui+BJLcRXOj38l3qjD/l6EYBjnOck+Yzqx54KkZ4ruPEpl8+Tdonnq0QiS9EBulClhuRolKuOnUZHc+lAGvp+g6RpTu+l6XZ2bSNudreBULH1JA5ryH4gwRH4yi7vZ1tbKxsrG7uLhzhUSO7DE/ngfjXpfhRbYfaRb2t1ZOu0Pbss6wKOdpj81FGSOu0cd/WvJ/G8P8AbXxM2+WHhv8AUo9KdXcgPHE1rJJgHAz16Z70Ae4213/aGkQ3lojobiBZYknUoy7lyAw6g88jtXAfYfEGg+OfD+q6vcJeveSSaZcyxspJjZWkj3BY4xhXQYPJ+dvWvSa4XxX4k0+48Y+GdCsL22ub8asGubdJA0kKLDIxJA6chevrQB3VFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUjMFUsxwAMk0tYHjvUJdK8A63eW24TpZyCHYCT5jDanTn7xFAFDwAn2+11LxNIdz63dtJE2ScW8Z8uIDPYhS3/AAOuuqrpWnxaTo9np1v/AKmzgSCP/dRQo/QVaoAKKzG1uCC6+zanDJZl22xySjMcn0ccD6HFV7LUrfSrPULfUJhEulq0rvI3/LDBYP8AQDI/4DigDJ8PQw3fxO8Vamm0vBHa6ecdQVUyHPH/AE0WuxrmfAVjc23htr7UY2hvdXuJNRniYnMRkxtQ57qgRT7g101ADJpVhheWQ4VFLMfQAZr58tPP1I+G9fuLaaKzt9dF88xtnijiW4lIDu7qu4sGiHygqAMk817D8Rbh7b4d615GfOmtWt4sEffk/dr146sKz/DOnR+IfhfLoGpzO/l/aNOkdQEaMJIyIRjoQoQj6CgDp9cvzpfh/UdQUbjaWss4HrtQt/SuBg0qHTfCfgSAH7Pdzalb3Eruo8yeZo2eQtnks3zZPXGas/25Z6v4Z1DwZ46v00jV/srWk80zCJbpSNoniZsBg3Xb1BJBrm7rX9XTXdGu2nsPEPhrQbmOW41O1tzEImZHg4+Zlk2+ZvJXpt96APZ6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArnfHv/ACJV7/vRf+jUroq5X4lXX2PwHdSbN+64tYsZxjfcxpn8N2aAOqooqO4laG3eRIXnZVyI48bnPoMkD8yKAC4t4bq3eC5iSaGRdrxuuVYehBrzjWfDI1TxnY+Go7kz6VHF9rvkZ2MscAb5bYtn5oncAhTyBGw6NXTaxf6xZ6deale3Vpo+nW8LO22Mzz4AODkkID0+Xa31Oai8A6NeWGjy6lrjPJrOrSfabxpVCsgxiOPA4G1MDHrmgDqqKKKAOO+JUDaho2k6Ut6bI6hrFrF5qorN8j+b8oYEZ/dZ5BHHQ9Kz4km+GusXN3qd/eahoGqN511eTqpNlcYAMj7FAEbgDkDgjnrWr4tjW88V+DbJoi4XU5bxmDY2iK2lA47/ADSJUPjYtrupab4NgJ2agftOpEfw2cZGV/7aNhPpvoAt+Gbi48U2c+sarbRHTruQNpdtLANy24HErZ53P97HYbR1zWP4yuLzS9D16DULWM6NLZSGIRhTHEFU8AAA7icfKQR3DdVHfKqooVAFVRgADgCuJ+IGpWkur+GfDF1OsQ1fUBJKHOFaKHDlSf8Aafy0A77qAOv08Mul2ocEMIUBB652irFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxnxY/5J3cf9f1h/6WQ12dcd8VUaT4fTJGpZ2v7AKqjJJ+2Q8UAdjRRRQByFzt8Z+KTZDD6Loc6tc+lxeLhlj91j4Y/7W0fwmuvqOGCG3Vlt4kiVnZ2CKFBZjlicdySST3NSUAFFFFAHM6nBHL8UfDryLuaHTNReM/3T5loufyYj8ah8Lo174x8UatMpDLcpp8JOOEiQMcfVnJqW/ff8VNDjjcbo9Iv2lXaT8rS2oXntkqfyNQeH7oaR4x1vRNQxFJfXR1CxduBcIyqHVT3ZSvI64INADNShuPF3iqfSo765tNH0pUN2bOQxvcXDfMIi45CqmCQME71riPsMkd/4uF20uo6RaQNpltqdxNmS0ESCcqSRziV9u48kxqM5HOjpfje18EeG7nTtdgks/FVzPPOILlMLf3EkhAaN+jJyg7EKB6Vq3OjlLPRvA0U7Ty3THUNXnbBLRB98hb3klYL9N3pQB2ujS3E+hWEt9xcyW0bTf75UFv1zV2iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5nxw5az0e0Doputbsh8wyT5cwmIHviL8s101cv4iZp/G/hG0VwBHcXN6ybCSwS3eLr2AM4/SgDqKKKKACiiigAooqnrGpwaNot5qV0cQ2sLSt74Gcfj0oA5/Rcan8SPEGpgEx2MEGlxNyAWG6WTHPPMijp/DWfeabp/i/wCKN5Z61apdW2h2MRghkXKiWYktIPcKigHtz61p+FE/4R3wCuoa7J5UzxyajqEjgDa75kfOPTOPwrC0fRfEM9w3jfSpIYtT1dP32nahuEZts5hXK5KSKvJOD98gjigDN0rwj4U1HxRq/iW80u2TRNDWW0tmmBdZGUE3Ep3Zyqn5F7Da2O1b3wq8PjTPD0uqypNHNqziWGK4cu9taLkW8GTzhUOfqzVm6N8P/EX2RdE1i+tYPC8VwssWmwyPPNsXDCJp2VdyF8kgrnAAz1r0wAKoCjAHAA7UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzClbz4rPgk/2bpAHU4BnlyRjpnECk/UV09cv4Zzc+LPFV8dxU3kVtGS2RtjhUEAdvnLUAdRRRRQAUUUUAFch4s83X9f03wtbZ+zllvtVcfw26N8kZ/66OMfRHrotY1W20PR7rUr5iIbaMuwH3mPZQO5JwAO5IrlbSafwh4Tvde1tDPrmqzCR4Uy2ZXO2G2TvtUFV/76bvQBNroPi7xRF4bjO7SrErc6uy4xI+Q0Vt+JG9h/dCj+KuxrE8JaHJoWgpFeusuo3Dtc306j/WzucsfoOg9gK26ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAEdlRGdzhVGSfQVzHw9Uv4TW+YMG1G5nvCGPP7yRiO3pirHjm9lsvBmofZT/pVwgtbcA4LSSEIoHvlq19Osk07S7WyiO5LaFYlJHUKAM/pQBZooooAKKKKAMnWNCj1u909r2TdZ2U32g22OJZR9wt7KeceuPSshIl8T+PTdOS2neHGMUI6rLeMvzt7+WjBR/tO3da0vF+ty6B4ZubuziE18+2CzhJ/wBZO52oPpk5PsDVnw9o8eg6Ba6dGzSNEuZZWOWlkY7ndj3LMST9aANKiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDH1nQ31fV9GnkmUWmnXDXMkBXJlkCFY+ewUtu+oFbFFFABRRRQAUUUUAcrrROqfEDQ9K2b4bJJNTn56MP3cX6sx/CuqrlvDpN5448UXrEsIZYLFMoQF2R72AJPOTKM4x2rqaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDP0nSU0r7aVkaV7y6e5kdhg5YAAfgFA+grQoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z" alt="" width="223" height="271" vspace="0" hspace="0" border="0" style="width:223px;height:271px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p><strong>In the management of premature labour</strong></p><p>Treatment with <em>VENTOLIN</em> Injection/Solution for Infusion should only be initiated by obstetricians/physicians experienced in the use of tocolytic agents. Ideally, it should be carried out in facilities adequately equipped to perform continuous monitoring of maternal and foetal health status.</p><p>Duration of treatment should not exceed 48 hours as data show that the main effect of tocolytic therapy is a delay in delivery of up to 48 hours.&nbsp; No statistically significant effect on perinatal mortality or morbidity has been observed in randomised, controlled trials.&nbsp; This delay may be used to administer glucocorticoids or to implement other measures known to improve perinatal health.</p><p><em>VENTOLIN</em> Injection/Solution for infusion should be administered as early as possible after the diagnosis of premature labour, and after evaluation of the patient to eliminate any contraindications to the use of <em>VENTOLIN</em> (see <em>Contraindications</em>). This should include an adequate assessment of the patient&#39;s cardiovascular status with continuous ECG monitoring throughout treatment (see <em>Warnings and Precautions</em>).</p><p>For this indication <em>VENTOLIN</em> Solution for Intravenous Infusion is recommended using a solution prepared as above. Infusion rates of 10 to 45 micrograms per minute are generally adequate to control uterine contractions but greater or lesser infusion rates may be required according to the strength and frequency of contractions. A starting rate of 10 micrograms per minute is recommended, increasing the rate at 10-minute intervals until there is evidence of patient response shown by diminution in strength, frequency or duration of contractions. Thereafter the infusion rate may be increased slowly until contractions cease. Careful attention should be given to cardio-respiratory function, including increases in pulse rate and changes in blood pressure, electrolytes, glucose and lactate levels and fluid balance monitoring. A maximum sustained maternal heart rate of 120 beats/min should not be exceeded.. Treatment should be discontinued should signs of pulmonary oedema or myocardial ischaemia develop (see <em>Warnings and Precautions and Adverse Reactions</em>).</p><p>Once uterine contractions have ceased the infusion rate should be maintained at the same level for 1 hour and then reduced by 50% decrements at 6-hourly intervals.</p><p>As an alternative procedure or to counteract inadvertent overdosage with oxytocic drugs, <em>VENTOLIN</em> Injection may be administered as a single injection by the intravenous route. The usual recommended dose is 100 to 250 micrograms of salbutamol. The dose may be repeated according to the response of the patient.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Non-i.v. formulations of salbutamol must not be used to arrest uncomplicated premature labour or threatened abortion.

OBSTETRIC
VENTOLIN injection/solution for infusion, when used in the management of premature labour, is contra-indicated in the following conditions:
	at a gestational age < 22 weeks.
intrauterine foetal death, known lethal congenital or lethal chromosomal malformation.
any condition of the mother or foetus in which prolongation of the                               pregnancy is hazardous.
	in patients with pulmonary hypertension, pre-existing ischaemic heart disease or those patients with significant risk factors for ischaemic heart disease.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bronchodilators should not be the only or main treatment in patients with severe or unstable asthma. Severe asthma requires regular medical assessment, including lung-function testing, as patients are at risk of severe attacks and even death.&nbsp; Physicians should consider using the maximum recommended dose of inhaled corticosteroid and/or oral corticosteroid therapy in these patients<strong>.</strong></p><p>&nbsp;</p><p>The dosage or frequency of administration should only be increased on medical advice.</p><p>&nbsp;</p><p>Patients being treated with Ventolin Injection may also be receiving short-acting inhaled bronchodilators to relieve symptoms. Increasing use of bronchodilators, in particular short-acting inhaled <!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman",serif'><span
style='mso-element:field-begin'></span>SYMBOL 98 \f &quot;Symbol&quot;</span><![endif]--><!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman",serif'><span
style='mso-element:field-end'></span></span><![endif]--><sub>2</sub>-agonists to relieve symptoms, indicates deterioration of asthma control.&nbsp;</p><p>&nbsp;</p><p>The patient should be instructed to seek medical advice if short-acting relief bronchodilator treatment becomes less effective, or more inhalations than usual are required. In this situation the patient should be assessed and consideration given to the need for increased anti-inflammatory therapy (e.g. higher doses of inhaled corticosteroid or a course of oral corticosteroid).</p><p>&nbsp;</p><p>Cardiovascular effects may be seen with sympathomimetic drugs, including salbutamol. There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischaemia associated with salbutamol.&nbsp; Patients with underlying severe heart disease (e.g. ischaemic heart disease, arrhythmia or severe heart failure) who are receiving salbutamol should be warned to seek medical advice if they experience chest pain or other symptoms of worsening heart disease. Attention should be paid to assessment of symptoms such as dyspnoea and chest pain, as they may be of either respiratory or cardiac origin.</p><p>&nbsp;</p><p>Salbutamol should be administered cautiously to patients suffering from thyrotoxicosis.</p><p>&nbsp;</p><p>Potentially serious hypokalaemia may result from b<sub>2</sub>-agonist therapy, mainly from parenteral and nebulised administration. Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. Serum potassium levels should be monitored in such situations.</p><p>&nbsp;</p><p>Severe exacerbations of asthma must be treated in the normal way.</p><p>&nbsp;</p><p>The use of Ventolin Injection in the treatment of severe bronchospasm does not obviate the requirement for corticosteroid therapy as appropriate. When practicable, administration of oxygen concurrently with Ventolin Injection is recommended. In common with other b-adrenoceptor agonists, salbutamol can induce reversible metabolic changes such as hypokalaemia and increased blood glucose levels. Diabetic patients may be unable to compensate for the increase in blood glucose and the development of ketoacidosis has been reported. Concurrent administration of corticosteroids can exaggerate this effect. Diabetic patients and those concurrently receiving corticosteroids should be monitored frequently.</p><p>&nbsp;</p><p>Lactic acidosis has been reported in association with high therapeutic doses of intravenous and nebulised short-acting beta-agonist therapy, mainly in patients being treated for an acute asthma exacerbation (see Section 4.8). Increase in lactate levels may lead to dyspnoea and compensatory hyperventilation, which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short-acting beta-agonist treatment. It is therefore recommended that patients are monitored for the development of elevated serum lactate and consequent metabolic acidosis in this setting.</p><p>&nbsp;</p><p>As maternal pulmonary oedema has been reported during or following management of premature labour with b<sub>2</sub>-agonists, careful attention should be given to fluid balance and cardio-respiratory function should be monitored. If signs of pulmonary oedema develop, discontinuation of treatment should be considered (see section 4.8).</p><p>&nbsp;</p><p>Obstetric use only:</p><p>In the treatment of premature labour, before <em>VENTOLIN</em> parenteral preparations are given to any patient with known or suspected heart disease, an adequate assessment of the patient&#39;s cardiovascular status should be made by a physician experienced in cardiology.</p><p>Tocolysis with <em>VENTOLIN</em> parenteral preparations is not recommended when membranes have ruptured or the cervix has dilated beyond 4 cm.As maternal pulmonary oedema and myocardial ischaemia have been reported during or following treatment of premature labour with beta-2&nbsp;agonists, careful attention should be given to fluid balance and cardio-respiratory function, including ECG should be monitored. If signs of pulmonary oedema or myocardial ischaemia develop, discontinuation of treatment should be considered. (see <em>Dosage and Administration and Adverse Reactions</em>)</p><p>In the treatment of premature labour by intravenous infusion of <em>VENTOLIN</em> increases in maternal heart rate of the order 20 to 50 beats per minute usually accompany the infusion. The maternal pulse rate should be monitored and not normally allowed to exceed a sustained rate of 120 beats per minute.&nbsp; The effect of infusion on foetal rate is less marked but increases of up to 20 beats per minute may occur.</p><p>Maternal blood pressure may fall slightly during the infusion; the effect being greater on diastolic than on systolic pressure. Falls in diastolic pressure are usually within the range of 10 to 20mmHg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Salbutamol and non-selective beta-blocking drugs such as propranolol, should not usually be prescribed together.</p><p><em>VENTOLIN</em> is not contra-indicated in patients under treatment with monoamine oxidase inhibitors (MAOIs).</p><p>Owing to the additional antihypertensive effect, there is increased uterine inertia with risk of haemorrhage; in addition, serious ventricular rhythm disorders due to increased cardiac reactivity have been reported on interaction with halogenated anaesthetics. Treatment should be discontinued, whenever possible, at least 6 hours before any scheduled anaesthesia with halogenated anaesthetics.</p><p>Systemic corticosteroids are frequently given during premature labour to enhance foetal lung development. There have been reports of pulmonary oedema in women concomitantly administered with beta-agonists and corticosteroids. Corticosteroids are known to increase blood glucose and can deplete serum potassium, therefore concomitant administration should be undertaken with caution with continuous patient monitoring owing to the increased risk of hyperglycaemia and hypokalaemia.</p><p>The administration of beta-agonists is associated with a rise of blood glucose, which can be interpreted as an attenuation of anti-diabetic therapy; therefore individual anti-diabetic therapy may need to be adjusted.</p><p>Owing to the hypokalaemic effect of beta-agonists, concurrent administration of serum potassium depleting agents known to exacerbate the risk of hypokalaemia, such as diuretics, digoxin, methyl xanthines and corticosteroids, should be administered cautiously after careful evaluation of the benefits and risks with special regard to the increased risk of cardiac arrhythmias arising as a result of hypokalaemia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Administration of drugs during pregnancy should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus.&nbsp;</p><p>&nbsp;</p><p>As with the majority of drugs, there is little published evidence of the safety of salbutamol in the early stages of human pregnancy, but in animal studies there was evidence of some harmful effects on the foetus at very high dose levels.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>As salbutamol is probably secreted in breast milk its use in nursing mothers is not recommended unless the expected benefits outweigh any potential risk. In such situations the use of the inhaled route may be preferable although it is not known whether salbutamol has a harmful effect on the neonate.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>There is no information on the effects of salbutamol on human fertility. There were no adverse effects on fertility in animals (see section 5.3).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events are listed below by system organ class and frequency.&nbsp; Frequencies are defined as: very common (&sup3;1/10), common (&sup3;1/100 and &lt;1/10), uncommon (&sup3;1/1000 and &lt;1/100), rare (&sup3;1/10,000 and &lt;1/1000) and very rare (&lt;1/10,000).&nbsp; Very common and common events were generally determined from clinical trial data.&nbsp; Rare, very rare and unknown events were generally determined from spontaneous data.</p><p><strong>Immune system disorders</strong></p><p>&nbsp;</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions including angioedema, urticaria, bronchospasm, hypotension and collapse.</p><p>&nbsp;</p><p>Metabolism and nutrition disorders</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypokalaemia.</p><p>&nbsp;</p><p>Potentially serious hypokalaemia may result from beta-agonist therapy.</p><p>&nbsp;</p><p>Unknown: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactic acidosis (see section 4.4)</p><p>&nbsp;</p><p>&nbsp;</p><p>Nervous system disorders</p><p>Very common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor.</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperactivity.</p><p>&nbsp;</p><p><strong>Cardiac disorders</strong></p><p>&nbsp;</p><p>Very common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tachycardia.</p><p>&nbsp;</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Palpitations.</p><p>&nbsp;</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and extrasystoles.</p><p>&nbsp;</p><p>Unknown:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myocardial ischaemia* ( see section 4.4)</p><p>&nbsp;</p><p>&nbsp;</p><p>Vascular disorders</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peripheral vasodilatation.</p><p>&nbsp;</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p>&nbsp;</p><p>Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pulmonary oedema.</p><p>&nbsp;</p><p>In the management of pre-term labour, Ventolin Injection has uncommonly been associated with pulmonary oedema. Patients with predisposing factors including multiple pregnancies, fluid overload, maternal infection and pre-eclampsia may have an increased risk of developing pulmonary oedema.</p><p>&nbsp;</p><p>Gastrointestinal disorders</p><p>Unknown:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea, vomiting *.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Musculoskeletal and connective tissue disorders</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle cramps.</p><p>&nbsp;</p><p><strong>Injury, poisoning and procedural complications</strong></p><p>&nbsp;</p><p>Unknown:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slight pain or stinging on intramuscular use of undiluted injection*.</p><p>&nbsp;</p><p>* reported spontaneously in post-marketing data therefore frequency regarded as</p><p>unknown.</p><p>&nbsp;</p><p><strong><em>To report any Undesirable Effects:</em></strong></p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext: 2317-2356-2340</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p><p><strong>&nbsp;</strong></p><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: sa.aermi-saudi@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; website: https://healthksa.gsk.com/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most common signs and symptoms of overdose with salbutamol are transient beta agonist pharmacologically mediated events, including tachycardia, tremor, hyperactivity and metabolic effects including hypokalaemia and lactic acidosis (see sections 4.4 and 4.8).</p><p>&nbsp;</p><p>Hypokalaemia may occur following overdose with salbutamol. Serum potassium levels should be monitored.</p><p>&nbsp;</p><p>Lactic acidosis has been reported in association with high therapeutic doses as well as overdoses of short-acting beta-agonist therapy, therefore monitoring for elevated serum lactate and consequent metabolic acidosis (particularly if there is persistence or worsening of tachypnea despite resolution of other signs of bronchospasm such as wheezing) may be indicated in the setting of overdose.</p><p>&nbsp;</p><p>Nausea, vomiting and hyperglycaemia have been reported, predominantly in children and when salbutamol overdose has been taken via the oral route.</p><p>&nbsp;</p><p>Further management should be as clinically indicated or as recommended by the national poisons centre, where available.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Selective beta-2-adrenoreceptor agonists</p><p>ATC Code: R03CC02</p><p>&nbsp;</p><p>Salbutamol is a selective beta-<sub>2</sub> adrenoceptor agonist. At therapeutic doses it acts on beta-<sub>2</sub> adrenoceptors of bronchial muscle providing short-acting (4-6 hour) bronchodilation in reversible airways obstruction.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Salbutamol administered intravenously has a half-life of 4 to 6 hours and is cleared partly renally and partly by metabolism to the inactive 4&rsquo;-O-sulphate (phenolic sulphate) which is also excreted primarily in the urine. The faeces are a minor route of excretion. The majority of a dose of salbutamol given intravenously, orally or by inhalation is excreted within 72 hours. Salbutamol is bound to plasma proteins to the extent of 10%.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In common with other potent selective &beta;2-agonists, salbutamol has been shown to be teratogenic in mice when given subcutaneously. In a reproductive study, 9.3% of fetuses were found to have cleft palate at 2.5mg/kg dose, 4 times the maximum human oral dose. In rats, treatment at the levels of 0.5, 2.32, 10.75 and 50mg/kg/day orally throughout pregnancy resulted in no significant fetal abnormalities. The only toxic effect was an increase in neonatal mortality at the highest dose level as the result of lack of maternal care. Reproductive studies in the rabbit at doses of 50mg/kg/day orally (i.e. much higher than the normal human dose) have shown fetuses with treatment related changes; these included open eyelids (ablepharia), secondary palate clefts (palatoschisis), changes in ossification of the frontal bones of the cranium (cranioschisis) and limb flexure.</p><p><s>&nbsp;</s></p><p>In an oral fertility and general reproductive performance study in rats at doses of 2 and 50 mg/kg/day, with the exception of a reduction in number of weanlings surviving to day 21 post partum at 50 mg/kg/day, there were no adverse effects on fertility, embryofetal development, litter size, birth weight or growth rate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>Sodium hydroxide pellets</p><p>Dilute sulfuric acid</p><p>Water for injections</p><p>Nitrogen (oxygen free)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
24 hours – shelf life of admixtures with infusion fluids.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C and keep the ampoule in the outer container in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clear, neutral glass ampoules, packed in plastic trays with a cardboard sleeve over the trays.</p><p>&nbsp;</p><p>Pack size: 1ml ampoules in plastic trays of 5.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The only recommended diluents for Ventolin Injection are water for injections BP, sodium chloride injection BP, sodium chloride and dextrose injection BP or dextrose injection BP.</p><p>&nbsp;</p><p>All unused admixtures of Ventolin Injection should be discarded 24 hours after preparation.</p><p>&nbsp;</p><p>Ventolin Injection should not be administered in the same syringe as any other medication.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder
GlaxoSmithKline S.p.A *, Parma – Italy
*member of the GlaxoSmithKline group of companies

Manufacturing Site
GlaxoSmithKline S.p.A *, Parma – Italy
*member of the GlaxoSmithKline group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version Number: UK SPC v13
Date of Issue: 05 Feb 2015


VENTOLIN is a trademark owned by or licenced to GSK group of companies
©2019 GSK group of companies, all rights reserved.


            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>